NASDAQ:DCGO DocGo (DCGO) Stock Price, News & Analysis $2.20 -0.03 (-1.35%) Closing price 04:00 PM EasternExtended Trading$2.19 -0.01 (-0.23%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About DocGo Stock (NASDAQ:DCGO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get DocGo alerts:Sign Up Key Stats Today's Range$2.18▼$2.2650-Day Range$2.07▼$4.4452-Week Range$2.02▼$5.68Volume1.02 million shsAverage Volume744,625 shsMarket Capitalization$224.36 millionP/E Ratio7.86Dividend YieldN/APrice Target$4.89Consensus RatingModerate Buy Company OverviewDocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.Read More… DocGo Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks52nd Percentile Overall ScoreDCGO MarketRank™: DocGo scored higher than 52% of companies evaluated by MarketBeat, and ranked 402nd out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingModerate Buy Consensus RatingDocGo has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 5 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageDocGo has only been the subject of 3 research reports in the past 90 days.Read more about DocGo's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth-68.00% Earnings GrowthEarnings for DocGo are expected to decrease by -68.00% in the coming year, from $0.25 to $0.08 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of DocGo is 7.80, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 21.77.Price to Earnings Ratio vs. SectorThe P/E ratio of DocGo is 7.80, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 22.58.Price to Earnings Growth RatioDocGo has a PEG Ratio of 14.16. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDocGo has a P/B Ratio of 0.75. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about DocGo's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.59% of the float of DocGo has been sold short.Short Interest Ratio / Days to CoverDocGo has a short interest ratio ("days to cover") of 7.2.Change versus previous monthShort interest in DocGo has recently increased by 11.53%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDocGo does not currently pay a dividend.Dividend GrowthDocGo does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted7.59% of the float of DocGo has been sold short.Short Interest Ratio / Days to CoverDocGo has a short interest ratio ("days to cover") of 7.2.Change versus previous monthShort interest in DocGo has recently increased by 11.53%, indicating that investor sentiment is decreasing significantly. News and Social Media3.2 / 5News Sentiment1.71 News SentimentDocGo has a news sentiment score of 1.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.84 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for DocGo this week, compared to 2 articles on an average week.MarketBeat FollowsOnly 1 people have added DocGo to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, DocGo insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.70% of the stock of DocGo is held by insiders.Percentage Held by Institutions56.44% of the stock of DocGo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about DocGo's insider trading history. Receive DCGO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DocGo and its competitors with MarketBeat's FREE daily newsletter. Email Address DCGO Stock News HeadlinesDocGo Inc. (NASDAQ:DCGO) Receives $4.89 Consensus PT from BrokeragesApril 22, 2025 | americanbankingnews.comDocGo to Announce First Quarter Results on Thursday, May 8, 2025April 21, 2025 | businesswire.comSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.May 1, 2025 | Stansberry Research (Ad)Is DocGo Inc. (DCGO) the Best Quality Penny Stock to Buy According to Hedge Funds?April 19, 2025 | finance.yahoo.comDOCGO INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of DocGo Inc. - DCGOApril 18, 2025 | prnewswire.comIs DocGo Inc. (DCGO) the Best Quality Penny Stock to Buy According to Hedge Funds?April 18, 2025 | insidermonkey.com11 Best Quality Penny Stocks to Buy According to Hedge FundsApril 17, 2025 | insidermonkey.comDocGo management to meet with BTIGApril 10, 2025 | markets.businessinsider.comSee More Headlines DCGO Stock Analysis - Frequently Asked Questions How have DCGO shares performed this year? DocGo's stock was trading at $4.24 at the start of the year. Since then, DCGO stock has decreased by 48.5% and is now trading at $2.1850. View the best growth stocks for 2025 here. How were DocGo's earnings last quarter? DocGo Inc. (NASDAQ:DCGO) issued its quarterly earnings data on Thursday, November, 7th. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.01. The firm earned $138.68 million during the quarter, compared to analyst estimates of $139.59 million. DocGo had a trailing twelve-month return on equity of 8.90% and a net margin of 4.35%. Read the conference call transcript. Who are DocGo's major shareholders? Top institutional shareholders of DocGo include WCM Investment Management LLC (3.18%), P.A.W. Capital Corp (1.96%), Harbor Capital Advisors Inc. (1.34%) and Bank of New York Mellon Corp (0.36%). Insiders that own company stock include Lee Bienstock, Adriaan Stephanus Oberholzer, James M Travers, Anthony Capone, Ely D Tendler and Stephen Sugrue. View institutional ownership trends. How do I buy shares of DocGo? Shares of DCGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of DocGo own? Based on aggregate information from My MarketBeat watchlists, some other companies that DocGo investors own include Meta Platforms (META), NVIDIA (NVDA), CrowdStrike (CRWD), Adobe (ADBE), Broadcom (AVGO), Arista Networks (ANET) and ServiceNow (NOW). Company Calendar Last Earnings11/07/2024Today5/01/2025Next Earnings (Estimated)5/08/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health services Sub-IndustryHealthcare Current SymbolNASDAQ:DCGO CIK1822359 Webwww.docgo.com Phone844-443-6246FaxN/AEmployees2,920Year FoundedN/APrice Target and Rating Average Stock Price Target$4.89 High Stock Price Target$7.00 Low Stock Price Target$2.85 Potential Upside/Downside+121.8%Consensus RatingModerate Buy Rating Score (0-4)2.83 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)$0.17 Trailing P/E Ratio7.88 Forward P/E Ratio8.82 P/E Growth14.16Net Income$6.86 million Net Margins4.35% Pretax Margin6.69% Return on Equity8.90% Return on Assets5.72% Debt Debt-to-Equity RatioN/A Current Ratio2.19 Quick Ratio2.19 Sales & Book Value Annual Sales$616.56 million Price / Sales0.36 Cash Flow$0.09 per share Price / Cash Flow23.62 Book Value$2.93 per share Price / Book0.75Miscellaneous Outstanding Shares101,983,000Free Float99,296,000Market Cap$224.87 million OptionableOptionable Beta1.12 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report This page (NASDAQ:DCGO) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DocGo Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DocGo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.